- Home
- DGX
as of 12-15-2025 3:36pm EST
$184.09
+$1.65
+0.90%
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Chart Type:
Time Range:
| Founded: | 1967 | Country: | United States |
| Employees: | N/A | City: | SECAUCUS |
| Market Cap: | 20.5B | IPO Year: | 1996 |
| Target Price: | $194.07 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 8.51 | EPS Growth: | 14.49 |
| 52 Week Low/High: | $148.70 - $197.55 | Next Earning Date: | 01-29-2026 |
| Revenue: | $10,850,000,000 | Revenue Growth: | 13.74% |
| Revenue Growth (this year): | 12.37% | Revenue Growth (next year): | 3.52% |
AI-Powered DGX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 73.68%
73.68%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Quest Diagnostics Incorporated (DGX)
DELANEY MARK E
Sell
SVP & Chief Commercial Officer
DGX Nov 18, 2025
Avg Cost/Share
$187.35
Shares
7,946
Total Value
$1,488,683.10
Owned After
7,530
SEC Form 4
PFEIFFER GARY M
Sell
Director
DGX Oct 22, 2025
Avg Cost/Share
$182.40
Shares
1,482
Total Value
$270,316.80
Owned After
29,431
SEC Form 4
PREVOZNIK MICHAEL E
Sell
SVP & General Counsel
DGX Sep 26, 2025
Avg Cost/Share
$187.94
Shares
227
Total Value
$42,706.01
Owned After
38,261
PREVOZNIK MICHAEL E
Sell
SVP & General Counsel
DGX Sep 24, 2025
Avg Cost/Share
$187.02
Shares
175
Total Value
$32,729.02
Owned After
38,261
SEC Form 4
PREVOZNIK MICHAEL E
Sell
SVP & General Counsel
DGX Sep 23, 2025
Avg Cost/Share
$187.12
Shares
28,288
Total Value
$5,293,312.79
Owned After
38,261
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| DELANEY MARK E | DGX | SVP & Chief Commercial Officer | Nov 18, 2025 | Sell | $187.35 | 7,946 | $1,488,683.10 | 7,530 | |
| PFEIFFER GARY M | DGX | Director | Oct 22, 2025 | Sell | $182.40 | 1,482 | $270,316.80 | 29,431 | |
| PREVOZNIK MICHAEL E | DGX | SVP & General Counsel | Sep 26, 2025 | Sell | $187.94 | 227 | $42,706.01 | 38,261 | |
| PREVOZNIK MICHAEL E | DGX | SVP & General Counsel | Sep 24, 2025 | Sell | $187.02 | 175 | $32,729.02 | 38,261 | |
| PREVOZNIK MICHAEL E | DGX | SVP & General Counsel | Sep 23, 2025 | Sell | $187.12 | 28,288 | $5,293,312.79 | 38,261 |
Latest Quest Diagnostics Incorporated News
DGX Breaking Stock News: Dive into DGX Ticker-Specific Updates for Smart Investing
Compare DGX vs Leading Stocks
See how DGX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "DGX Quest Diagnostics Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.